AI Revolution taking off in Saudi Arabia, creating major opportunities for US tech stocks. Trump’s visit & trade deal with China add to bullish outlook. read more
Sanofi plans $20 billion US investment by 2030 to expand R&D and manufacturing, aiming to boost medicine production and job creation across states. read more
American Eagle shares tumble as analyst cuts FY25 outlook after weak Q1 update. Latest Ratings for AEO Date Firm Action From To Mar 2022 Morgan Stanley Maintains Equal-Weight Mar 2022 Deutsche Bank Maintains Buy Mar 2022 JP Morgan Maintains Overweight View More Analyst Ratings for AEO View the Latest Analyst Ratings read more
The top 10 richest people in the world are worth less than they were in 2024. Here’s a look at the gains and losses for top billionaires year-to-date. read more
Coinbase (COIN) experiencing breakout moment, soaring 47% in past month due to S&P 500 inclusion and acquisition of Deribit. Technicals also strong. read more
CMS draft expands drug price talks to include Medicare Part B drugs and outlines steps for future renegotiations; public comments due by June 26. read more
FDA grants accelerated approval to AbbVie’s Emrelis for c-Met overexpressing NSCLC; siRNA partnership with ADARx includes $335 million upfront. read more
Major cryptocurrencies are trading sideways amid stagnating Bitcoin dominance, potentially signaling increased capital rotation into altcoins. read more
Merck’s Welireg wins FDA approval for rare PPGL tumors; Q1 2025 sales reach $137M, marking a 62% year-over-year increase. read more
Silicon Laboratories reported Q1 results, with revenues of $178 million, as inventory levels are being well-managed, analysts say. Latest Ratings for SLAB Date Firm Action From To Mar 2022 Needham Maintains Buy Dec 2021 Wells Fargo Maintains Overweight Dec 2021 Morgan Stanley Maintains Equal-Weight View More Analyst Ratings for SLAB View the Latest Analyst Ratings…